Literature DB >> 2572179

Genetic heterogeneity in Peruvian Leishmania isolates.

N E Reiner1, R Lo, A Llanos-Cuentas, H Guerra, L L Button, W R McMaster.   

Abstract

Leishmania were isolated from Peruvian patients with uta or espundia; genomic DNA was examined for restriction fragment length differences by Southern blot analysis using DNA probes for beta-tubulin and for the major surface antigen gp63. Using 5 different restriction endonucleases, Peruvian isolates show homogeneity when examined at the beta-tubulin locus. In contrast, the organisms demonstrated heterogeneity both within and between disease groups when examined for restriction site differences within the gp63 locus. The differences observed did not correlate with the 2 disease groups. Comparison of these Peruvian isolates to New World reference strains of the Leishmania braziliensis complex reveals no consistent pattern of identity with either L. b. guyanensis, L. b. panamensis, or L. b. braziliensis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2572179     DOI: 10.4269/ajtmh.1989.41.416

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  3 in total

1.  Molecular epidemiology of Leishmania (Viannia) guyanensis in French Guiana.

Authors:  Brice Rotureau; Christophe Ravel; Mathieu Nacher; Pierre Couppié; Isabelle Curtet; Jean-Pierre Dedet; Bernard Carme
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

2.  Multiclonal Leishmania braziliensis population structure and its clinical implication in a region of endemicity for American tegumentary leishmaniasis.

Authors:  A Schriefer; A L F Schriefer; A Góes-Neto; L H Guimarães; L P Carvalho; R P Almeida; P R Machado; H A Lessa; A Ribeiro de Jesus; L W Riley; E M Carvalho
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

3.  Leishmania isoenzyme polymorphisms in Ecuador: relationships with geographic distribution and clinical presentation.

Authors:  Manuel Calvopina; Rodrigo X Armijos; Jorge D Marco; Hiroshi Uezato; Hirotomo Kato; Eduardo A Gomez; Masataka Korenaga; Paola A Barroso; Tatsuyuki Mimori; Philip J Cooper; Shigeo Nonaka; Yoshihisa Hashiguchi
Journal:  BMC Infect Dis       Date:  2006-09-13       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.